These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35833874)

  • 1. Solutions for surrogacy validation with longitudinal outcomes for a gene therapy.
    Roberts EK; Elliott MR; Taylor JMG
    Biometrics; 2023 Sep; 79(3):1840-1852. PubMed ID: 35833874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm.
    Roberts EK; Elliott MR; Taylor JMG
    Stat Med; 2021 Dec; 40(29):6605-6618. PubMed ID: 34528260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.
    Conlon AS; Taylor JM; Elliott MR
    Biostatistics; 2014 Apr; 15(2):266-83. PubMed ID: 24285772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models.
    Taylor JM; Conlon AS; Elliott MR
    Clin Trials; 2015 Aug; 12(4):317-22. PubMed ID: 25490988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accommodating missingness when assessing surrogacy via principal stratification.
    Elliott MR; Li Y; Taylor JM
    Clin Trials; 2013; 10(3):363-77. PubMed ID: 23553326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogacy validation for time-to-event outcomes with illness-death frailty models.
    Roberts EK; Elliott MR; Taylor JMG
    Biom J; 2024 Jan; 66(1):e2200324. PubMed ID: 37776057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links between causal effects and causal association for surrogacy evaluation in a gaussian setting.
    Conlon A; Taylor J; Li Y; Diaz-Ordaz K; Elliott M
    Stat Med; 2017 Nov; 36(27):4243-4265. PubMed ID: 28786131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogacy assessment using principal stratification and a Gaussian copula model.
    Conlon A; Taylor J; Elliott MR
    Stat Methods Med Res; 2017 Feb; 26(1):88-107. PubMed ID: 24947559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal assessment of surrogacy in a meta-analysis of colorectal cancer trials.
    Li Y; Taylor JM; Elliott MR; Sargent DJ
    Biostatistics; 2011 Jul; 12(3):478-92. PubMed ID: 21252079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian approach to improved estimation of causal effect predictiveness for a principal surrogate endpoint.
    Zigler CM; Belin TR
    Biometrics; 2012 Sep; 68(3):922-32. PubMed ID: 22348277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bayesian approach to surrogacy assessment using principal stratification in clinical trials.
    Li Y; Taylor JM; Elliott MR
    Biometrics; 2010 Jun; 66(2):523-31. PubMed ID: 19673864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomes.
    Elliott MR; Raghunathan TE; Li Y
    Biostatistics; 2010 Apr; 11(2):353-72. PubMed ID: 20101045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A maximum entropy approach for the evaluation of surrogate endpoints based on causal inference.
    Alonso A; Van der Elst W; Molenberghs G
    Stat Med; 2018 Dec; 37(29):4525-4538. PubMed ID: 30141219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of surrogate endpoints in cancer clinical trials via principal stratification with an application to a prostate cancer trial.
    Tanaka S; Matsuyama Y; Ohashi Y
    Stat Med; 2017 Aug; 36(19):2963-2977. PubMed ID: 28485043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.
    Zhou J; Chu H; Hudgens MG; Halloran ME
    Stat Med; 2016 Jan; 35(1):53-64. PubMed ID: 26194767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A refreshing account of principal stratification.
    Mealli F; Mattei A
    Int J Biostat; 2012; 8(1):. PubMed ID: 22611592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.
    Renfro LA; Shi Q; Sargent DJ; Carlin BP
    Stat Med; 2012 Apr; 31(8):743-61. PubMed ID: 22161275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing a surrogate predictive value: a causal inference approach.
    Alonso A; Van der Elst W; Meyvisch P
    Stat Med; 2017 Mar; 36(7):1083-1098. PubMed ID: 27966231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints.
    Bujkiewicz S; Thompson JR; Spata E; Abrams KR
    Stat Methods Med Res; 2017 Oct; 26(5):2287-2318. PubMed ID: 26271918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.